title: [Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - yes].
authors.affiliation: Abteilung Innere Medizin III, Kardiologie, Angiologie und Pulmologie, Universitätsklinik Heidelberg, Deutschland.
authors.forename: A
authors.initials: A
authors.lastname: Thanaraj
authors.forename: B
authors.initials: B
authors.lastname: Meder
mesh_terms: D001706:Biopsy; D009202:Cardiomyopathies / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D002311:Cardiomyopathy, Dilated / Q000235:genetics / Q000473:pathology / Q000628:therapy; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics / Q000473:pathology / Q000628:therapy; D004252:DNA Mutational Analysis; D004699:Endocardium / Q000473:pathology*; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D034904:Lamin Type A / Q000235:genetics; D009206:Myocardium / Q000473:pathology*; D010641:Phenotype; D011237:Predictive Value of Tests; D011379:Prognosis; D017422:Sequence Analysis, DNA
chemical_list: C494847:LMNA protein, human; D034904:Lamin Type A